Showing results (211-220 of 314) with videos related to

Sort By:
Pageof 32
Molecular Autism|August 28, 2020
Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysisSpyridon Siafis, Oğulcan Çıray, Johannes Schneider-Thoma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [68Ga]Ga-PSMA-11 PET/CT in the proPSMA StudyDavid C Chen, James P Buteau, Louise Emmett, et al.
The Medical Journal of Australia|June 4, 2013
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011Sue M Evans, Jeremy L Millar, Ian D Davis, et al.
BJU International|June 28, 2025
Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinomaMuhammad Ali, Mathias Bressel, David Chang, et al.
The International Journal of Neuropsychopharmacology|October 12, 2017
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal SymptomsGemma Modinos, Fatma Simsek, Jamie Horder, et al.
European Urology|September 20, 2018
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical TrialShankar Siva, Mathias Bressel, Declan G Murphy, et al.
Social Cognitive and Affective Neuroscience|December 31, 2015
Heritability of the limbic networksSanja Budisavljevic, Jamie M Kawadler, Flavio Dell'Acqua, et al.
BJU International|March 8, 2021
UpFrontPSMA: a randomized phase 2 study of sequential 177 Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol)Nattakorn Dhiantravan, Louise Emmett, Anthony M Joshua, et al.
Cancers|January 28, 2026
Nuclear Imaging in Renal Cell Carcinoma: Current Evidence and Clinical ApplicationsAbdullah Al-Khanaty, Shane Qin, Carlos Delgado, et al.
Biomaterials|April 9, 2013
A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancerAshlee K Clark, Anna V Taubenberger, Renea A Taylor, et al.
Pageof 32